Having trouble accessing articles? Reset your cache.

MLN4924: Preliminary Phase I data

Preliminary data from an ongoing, dose-escalation Phase I trial in 15 patients with AML or high-grade MDS

Read the full 174 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE